PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $184,000 | -62.9% | 35,592 | -72.5% | 0.00% | -50.0% |
Q2 2021 | $496,000 | +1277.8% | 129,608 | +643.6% | 0.00% | – |
Q3 2020 | $36,000 | -80.6% | 17,429 | -78.7% | 0.00% | -100.0% |
Q1 2020 | $186,000 | +14.8% | 81,758 | +82.7% | 0.01% | +400.0% |
Q4 2019 | $162,000 | +217.6% | 44,761 | +314.5% | 0.00% | – |
Q2 2019 | $51,000 | -64.3% | 10,800 | -61.8% | 0.00% | -100.0% |
Q2 2018 | $143,000 | +15.3% | 28,300 | +55.5% | 0.00% | 0.0% |
Q1 2018 | $124,000 | -69.2% | 18,200 | -65.8% | 0.00% | -71.4% |
Q4 2017 | $402,000 | – | 53,260 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |